- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$23.27 BnMarket Estimate, 2026
$25.06 BnMarket Forecast, 2034
$45.40 BnCAGR, 2026–2034
7.71%U.S. Patient Monitoring Market Size, Growth, Trends & Forecast (2026–2034)
The U.S. patient monitoring market size was valued at USD 23.27 billion in 2025, reached USD 25.06 billion in 2026, and is projected to reach USD 45.40 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.71% from 2026 to 2034. Propelled by advanced healthcare infrastructure, rising demand for mobile health and portable monitoring solutions, and robust public-private funding initiatives, the U.S. market continues to dominate the North American medical landscape.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 23.27 Billion
- 2026 Current Valuation: USD 25.06 Billion
- 2034 Forecast Valuation: USD 45.40 Billion
- Compound Annual Growth Rate (CAGR): 7.71% (2026–2034)
- Regional Standing: United States (Leading market position across the North American region)
Core Market Drivers & Growth Triggers
- Mobile Health (mHealth) Adoption: Increasing usage of mobile phones and portable monitoring devices enabling remote patient observations and decentralized care.
- Government & NGO Funding: Strong financial support for research and development, alongside active frontline healthcare networks.
Primary Market Restraints & Challenges
- Technological Barriers for Seniors: Digital literacy challenges among elderly patient demographics limiting online platform engagement and remote monitoring utilization.
- Regulatory & Clinical Complexities: Strict device approval guidelines and technical limitations associated with invasive monitoring instruments for fragile patients.
U.S. Patient Monitoring Market Overview & Scope
| Parameter Focus | Market Attribute Details |
|---|---|
| Core Functionality | Continuous and repeated observation of physiological functions, life support quality assurance, and vital task tracking |
| Geographic Coverage | United States (Dominant North American revenue contributor) |
Major Industry Players Profiled
Key corporations shaping the U.S. patient monitoring market include Covidien, Abbott Laboratories, Drägerwerk AG & Co. KGaA (Dräger Medical GmbH), GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus Medical Inc., Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn.
Download Free Sample Report
U.S. Patient Monitoring Market Size
The U.S. patient monitoring market was valued at USD 23.27 billion in 2025, is estimated to reach USD 25.06 billion in 2026, and is projected to reach USD 45.40 billion by 2034, growing at a CAGR of 7.71% from 2026 to 2034.
Patient monitoring system involves continuous and repeated observations for patients, monitoring patient's physiological functions, quality checking for life support equipment. This system also includes monitoring vital tasks for patients and provides easy access to patients in their location with portable devices and parameters.
The United States is considered a technologically developed country, and healthcare and infrastructure are top-notch for its economy. Healthcare workers, frontliners, physicians, and nursing staff are very active and massive. It adds to the benefit of the patient monitoring market. By this means of methods, a person can get treatment at their location and monitor medical staff. Government funding for the patient monitoring market helps this market size to grow. Along with the government, non-governmental organizations also show up in funding for this market. An increase in adaption and demand for the mobile health market increases the patient monitoring market through the ease of communication, safety, and measures.
The senior population with little knowledge of technology and devices does not use any technology mode to approach healthcare services on an online platform. For elderly patients, patient marketing services on the online platform are not recommended for safety concerns. There are difficulties associated with difficult cases and weak patients. It is not possible to insert monitoring instruments such as pulmonary devices. Few factors may also increase the mortality rate. For only a specific set of conditions, patient monitoring services are recommended. The stringent rules and regulations for the approvals hampered market growth, and this market's organizations made this stricter.
Country-Level Analysis
The US patient monitoring market is continuing to dominate the market and is presently leading the North American region. Increased adaption of mobile patient monitoring and increase usage of mobile phones contribute to market growth. Private and public organizations' investments and funds across this region developed market growth as well. Government investments for research and developmental activities also have a top benefit for this market in the United States.
Key Market Players
Companies like Covidien, Abbott Laboratories, Drager, Medical GmbH, GE Healthcare, Johnson & Johnson Inc., Masimo Corporation, Mindray Medical, Mortara Instrument Inc., Natus, Nihon Kohden, Nonin Medical, Omron Healthcare, Philips Healthcare, Roche Diagnostics Limited, and Welch Allyn are playing a significant role in the U.S. patient monitoring market.